Home/Filings/4/0001209191-21-003158
4//SEC Filing

Henig Noreen 4

Accession 0001209191-21-003158

CIK 0001645666other

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 9:12 PM ET

Size

5.5 KB

Accession

0001209191-21-003158

Insider Transaction Report

Form 4
Period: 2021-01-08
Henig Noreen
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-01-08+280,000280,000 total
    Exercise: $5.45Exp: 2031-01-07Common Stock (280,000 underlying)
Footnotes (1)
  • [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 1, 2021, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Kezar Life Sciences, Inc.

CIK 0001645666

Entity typeother

Related Parties

1
  • filerCIK 0001810995

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 9:12 PM ET
Size
5.5 KB